
Three-year-old boy shows early improvement after receiving investigational brain tumor treatment NEO100 in Abu Dhabi
NeOnc Technologies reported early clinical improvement in a critically ill three-year-old boy with an aggressive brain tumor treated with investigational intranasal NEO100 under compassionate use in Abu Dhabi. The child is now breathing independently...





